Evaluating artificial intelligence-based cardiovascular magnetic resonance segmentation methods: Comparability to manual segmentation and impact on effect size and sample size in the TRED-HF trial
9 May 2026 (08:00 - 12:45)
Organised by: 
About the speaker
Hasna Medika Group, Bandung (Indonesia)
5 More presentations in this session
Doctor L. Del Punta (Pisa, IT)
Access the full session
The Event
Heart Failure 2026
9 May - 12 May 2026
You may be interested in
Congress Presentation
